@IHIEurope Project on Combatting #BacterialResistance in Europe. Collaboration between academia&industry for the research & development of new drugs against AMR
Joined March 2017
- Tweets2.7K
- Following1.7K
- Followers1.9K
- Likes1.8K
Pinned Tweet
Thrilled to announce a brand new publication from COMBACTE-CARE's consortium in the @TheLancetInfDis on safety and efficacy of ATM-AVI for treating serious #infections caused by Gram-negative #bacteria 🦠
👉combacte.com/publications/az…
@IHIEurope @EFPIA @pfizer
COMBACTE retweeted
Have you registered? VITAL's final scientific symposium on #vaccination in older adults will highlight the latest research and strategies, as well as VITAL's sustainability in the future.
👉bit.ly/48a29kh
@DebbieBaarle @UMCG @RIVM @Sanofi @Ecraid
#HealthyAging #Vaccines
COMBACTE retweeted
Join us for our final scientific symposium on #vaccination in older adults and learn about the latest research and strategies, as well as VITAL's sustainability in the future.
vital-imi.eu/portfolio-item/…
@DebbieBaarle @UMCG @RIVM @GSK
#HealthyAging #Vaccines
COMBACTE retweeted
Thrilled to announce a brand new publication from COMBACTE-CARE's consortium in the @TheLancetInfDis on safety and efficacy of ATM-AVI for treating serious #infections caused by Gram-negative #bacteria 🦠
👉combacte.com/publications/az…
@IHIEurope @EFPIA @pfizer
COMBACTE retweeted
⏰Last chance to register for the Post-graduate course offered by @Ecraid in collaboration with @ESCMID. Enhance your skills with the help of top experts like @MarcBonten!
📝ecraid.eu/news/2024-postgrad…
📅 22-24 October 2024
📍 Belgrade, Serbia
⏳ Registration closes 6 October
⏰Last chance to register for the Post-graduate course offered by @Ecraid in collaboration with @ESCMID. Enhance your skills with the help of top experts like @MarcBonten!
📝ecraid.eu/news/2024-postgrad…
📅 22-24 October 2024
📍 Belgrade, Serbia
⏳ Registration closes 6 October
📣 Calling researchers in clinical microbiology and infectious diseases! Sharpen your skills and refine your research methodologies with this postgraduate course organised by @Ecraid and @ESCMID.
⏰ Limited spots left - register today!
This Post is from an account that no longer exists. Learn more
COMBACTE retweeted
📢 Read all about it! 🗞️ IHI's June newsletter is now live!➡️ europa.eu/!yKbHDh Find out:
☑️ Everything you wanted to know about call 8
☑️ New #EPI solutions
☑️ Research into whether #SmartHomes can predict onset of #dementia
☑️Events to catch up on
#IHITransformingHealth
ALT 📢 Read all about it! 🗞️ IHI's June newsletter is now live!➡️ https://europa.eu/!yKbHDh ☑️ Everything you wanted to know about call 8 ☑️ New #EPI solutions ☑️ Research into whether #SmartHomes can predict onset of #dementia ☑️Events to catch up on #IHITransformingHealth
COMBACTE retweeted
Our latest scientific paper dives into the influence of healthcare workers on older adults' #vaccine acceptance. Published in @BioMedCentral 👇 bit.ly/4evZu7y
@DebbieBaarle @RIVM @Radboud_Uni @VUamsterdam
#InfectiousDiseases #HealthyAging
Check the thread below on the latest COMBACTE-CARE publication on international and regional spread of #carbapenem-resistant #Klebsiella pneumoniae in Europe: bit.ly/4cpl0J0
@IHIEurope @EUScienceInnov @Uniklinik_Fr @MedMicroLab_UA @HUVMacarena @ciberinfec @ibis_sevilla
This Post is from an account that no longer exists. Learn more
Dive into our recent publication assessing the clinical presentation of invasive E. coli disease & #antimicrobialresistance patterns of causative E. coli isolates in older adults combacte.com/publications/cl…
@IHIEurope @JanssenUS @HUVMacarena @IenI_UMCUtrecht @MarcBonten @jesusrbano
Last week's @IHIEurope webinar featured our academic and pharmaceutical partners discussing the collaboration within the projects, and its outstanding milestones 👇
Watch now: bit.ly/4bNqMV1
@Ecraid @CHULimoges @Pfizer @UMCU_Intl @HorizonEU @EU_Commission @HUVMacarena
COMBACTE retweeted
Day2 of #UADays24 and ready to start with my lecture on the role of clinical trial networks in solving the global #AMR problem. Will address the evolution of @COMBACTE into @Ecraid @IHIEurope @EU_Commission
Aaaand we are here!!! Finally the Uppsala Antibiotic Days have come, sun shinning & blue skies! Follow #UADays24 to see what we are up to 🤓
or 💥FLASH NEWS💥 join the stream to watch any of the talks today and tomorrow if you didn’t get to register!👇🏻
bit.ly/UAD24stream
This Friday @IHIEurope will be hosting an impact webinar highlighting the significant outcomes of the COMBACTE projects in combating #antimicrobialresistance 🦠
The Legacy of the COMBACTE Projects: combacte.com/news/webinar-co…
@Ecraid @MarcBonten @jesusrbano @IenI_UMCUtrecht @EFPIA
Thinking of a bit of scientific reading this weekend? Look no further! This COMBACTE-NET paper on invasive E. coli disease (IED) explores results from our EXPECT-1 observational study
👉combacte.com/publications/fe…
@IHIEurope @SpringerNature @IenI_UMCUtrecht @Ecraid @JanssenUS
COMBACTE retweeted
💡If you're interested in the #AMR results from the @COMBACTE projects, join us on 31 May for our Impact webinar - Combatting antimicrobial restistance🦠: the legacy of the @COMBACTE projects. More info & register here: europa.eu/!V6mTBY
Today we celebrate #ClinicalTrialsDay recognising groundbreaking innovations, but more importantly the clinical researchers behind them. Their efforts, dedication & curiosity leading to these breakthroughs #CTD2024
@IHIEurope @EFPIA @IenI_UMCUtrecht @Ecraid @ACRPDC @EU_Commission
Today we celebrate #ClinicalTrialsDay recognising groundbreaking innovations, but more importantly the clinical researchers behind them. Their efforts, dedication & curiosity leading to these breakthroughs #CTD2024
@IHIEurope @EFPIA @IenI_UMCUtrecht @Ecraid @ACRPDC @EU_Commission
COMBACTE retweeted
Save the date - 31 May 2024 - to find how the @COMBACTE projects leveraged #PPP to combat #AntimicrobialResistance, which causes more than 35K deaths/year. Register now: europa.eu/!V6mTBY #EUResearch #EUInnovation
ALT Save the date - 31 May 2024 - to find how the @COMBACTE projects leveraged #PPP to combat #AntimicrobialResistance, which causes more than 35K deaths/year. Register now: https://europa.eu/!V6mTBY #EUResearch #EUInnovation
COMBACTE retweeted
🦠 The IMI-supported EMBLAVEO®, which received marketing authorisation from the European Commission last week, is desperately needed, says an infectious disease expert involved in the IMI-supported Phase III REVISIT trial.
👀 Read more: europa.eu/!QdG9tT
@COMBACTE